Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep;54(3):296-300.
doi: 10.1007/s00795-020-00276-0. Epub 2021 Jan 16.

A case of "ETV6-FISH-negative" secretory carcinoma of the parotid gland: immunohistochemical study

Affiliations
Case Reports

A case of "ETV6-FISH-negative" secretory carcinoma of the parotid gland: immunohistochemical study

Hiroshi Harada et al. Med Mol Morphol. 2021 Sep.

Abstract

Secretory carcinoma of the salivary glands is a relatively new disease concept, and is characterized by "morphological resemblance to mammary secretory carcinoma and ETV6-NTRK3 gene fusion." Herein we describe a confusing case and briefly discuss practical diagnostic problems. The patient was a 71-year-old Japanese man who had a tumor consistent with secretory carcinoma at the microscopic and immunohistochemical levels. Immunohistochemically, EMA and S100 protein were noted to be positive along with various cytokeratins as well as mammaglobin and pSTAT5. Moreover, vimentin was focally positive. Smooth muscle actin, p63, p40, and androgen receptor were negative. However, a search using fluorescence in situ hybridization did not reveal a definite split signal for the ETV6 gene. It is presumed that confirming the diagnosis of secretory carcinoma without genetic retrieval will be accepted as a diagnostic method, and we hope that worldwide general recognition may earlier reach "gradual acceptance."

Keywords: ETV6 gene; Fluorescence in situ hybridization; Immunohistochemistry; Secretory carcinoma; pSTAT5.

PubMed Disclaimer

Similar articles

References

    1. Hamamoto Y, Harada H, Kohara M, Honma K, Nakatsuka SI, Morii E (2020) Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland. Med Mol Morphol. https://doi.org/10.1007/s00795-020-00256-4 . (epub ahead of print)
    1. Skálová A, Vanecek T, Simpson RH, Laco J, Majewska H, Baneckova M, Steiner P, Michal M (2016) Mammary analogue secretory carcinoma of salivary glands. Molecular analysis of 25 ETV6 gene rearranged tumors with lack of detection of classical ETV6–NTRK3 fusion transcript by standard RT-PCR: report of 4 cases harboring ETV6-X gene fusion. Am J Surg Pathol 40:3–13 - DOI
    1. Skalova A, Vanecek T, Martinek P, Weinreb I, Stevens TM, Simpson RHW, Hyrcza M, Rupp NJ, Baneckova M, Michal M Jr, Slouka D, Svoboda T, Metelkova A, Etebarian A, Pavelka J, Potts SJ, Christiansen J, Steiner P, Michal M (2018) Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol 42:234–246 - DOI
    1. Rooper LM, Karantanos T, Ning Y, Bishop JA, Gordon SW, Kang H (2018) Salivary secretory carcinoma with a novel ETV6-MET fusion: expanding the molecular spectrum of a recently described entity. Am J Surg Pathol 42:1121–1126 - DOI
    1. Guilmette J, Dias-Santagata D, Nosé V, Lennerz JK, Sadow PM (2019) Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family. Hum Pathol 83:50–58 - DOI

MeSH terms

LinkOut - more resources